RxDoctor Payments DataLook up a doctor →

Rachael Wills, NP

Gerontology · Greenville, SCNPI 1841853728

Payments from drug & device makers

$8,480in general payments, 2019–2025

Across 498 payments — averaging $17.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$959
  • Novo Nordisk$834
  • Lilly USA, LLC$741
  • AstraZeneca$637
  • Bayer$579
  • Boehringer Ingelheim$305
  • plus $4K from 40 others

What the payments were for

  • Food & beverage$8,480100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,480 in reported general payments places this provider in the 95th percentile of 137 gerontology providers in South Carolina.

See all gerontology providers in South Carolina

Medicare billing

Part B allowed, 2024
$32,267
Medicare patients
205
Services billed
568

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban20$23,559
OzempicSemaglutide13$16,221
FarxigaDapagliflozin Propanediol16$14,369
JardianceEmpagliflozin13$9,489
SynthroidLevothyroxine Sodium18$769
Losartan Potassium46$717
Metoprolol Succinate43$617
Duloxetine Hcl16$614
Omeprazole27$587
Atorvastatin Calcium35$566
Rosuvastatin Calcium40$536
Levothyroxine Sodium49$450
Gabapentin15$340
Pantoprazole Sodium15$320
Amlodipine Besylate57$309

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$297$23,55920 claims
Novo NordiskOzempic$834$16,22113 claims
AstraZenecaFarxiga$637$14,36916 claims
Boehringer IngelheimJardiance$305$9,48913 claims
AbbVieSynthroid$959$76918 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$15$45049 claims
Almatica Pharma LLCSertraline Hcl$60$8818 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 137 gerontology providers in South Carolina.

Other gerontology in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →